RhythmAnalytics vs iCAC Device
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is automated, AI-driven interpretation of single-lead ECG data for the detection and classification of various cardiac arrhythmias. This tool is ideal for clinical settings requiring real-time or continuous monitoring of patients for conditions like AFib, ventricular arrhythmias, and ectopic beats, providing crucial clinical decision support.
View RhythmAnalytics →Choose iCAC Device if…
Choose iCAC Device if your goal is to opportunistically identify and quantify coronary artery calcium from routine, non-contrast chest CT scans to assess cardiovascular disease risk. This solution is best suited for integrating with existing radiology workflows to leverage previously acquired imaging data for early detection of atherosclerosis, aiding in proactive patient management.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | iCAC Device |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Cloud-based API | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iCAC DeviceTool B, iCAC Device, integrates with PACS/DICOM routers and its Carebricks platform enables clinicians to design and deploy AI agents for customized workflows, including visual outputs of CAC segmentation [cite: JSON, 22, 25, 31]. This suggests a more direct and customizable user experience for radiologists. Tool A, RhythmAnalytics, is primarily offered as a cloud-based API for integrators to build applications, implying a less direct user interface from the vendor itself.
Clinical Value
RhythmAnalyticsTool A, RhythmAnalytics, is FDA-cleared and demonstrated cardiologist-level accuracy in detecting over 15 types of cardiac arrhythmias, outperforming other deep learning systems and a panel of cardiologists with high sensitivity and specificity. This directly addresses high error rates in traditional ECG interpretation, offering a significant improvement in diagnostic accuracy. While Tool B, iCAC Device, provides valuable opportunistic screening for cardiovascular disease, Tool A's quantifiable superior performance against human experts in a critical diagnostic area gives it a slight edge in direct clinical impact.
Pricing & Value
iCAC DeviceBoth tools have opaque pricing, requiring direct vendor contact [cite: JSON]. However, Tool B, iCAC Device, has secured CMS reimbursement pathways for AI cardiovascular analysis. This established reimbursement mechanism provides a clearer path for healthcare providers to realize financial value and integrate the solution into their billing processes, offering a more transparent value proposition for enterprise adoption.
Enterprise Readiness
iCAC DeviceBoth tools are FDA-cleared, cloud-based, and integrate with major health systems and EHRs [cite: JSON, 5, 6, 15, 20, 23, 24, 28]. However, Tool B's iCAC Device explicitly integrates with PACS/DICOM routers and its Carebricks platform is designed for system-wide deployment, enabling clinician-led AI workflows across an entire health system, as demonstrated with UTMB Health [cite: JSON, 22, 25, 31]. This indicates a highly adaptable and scalable solution for complex enterprise environments, particularly within radiology.
Innovation
iCAC DeviceWhile Tool A, RhythmAnalytics, offers innovative AI-powered ECG interpretation [cite: JSON, 4, 5, 6], Tool B, iCAC Device, stands out with its 'opportunistic identification' of coronary artery calcium from routine, non-contrast, non-gated chest CT scans [cite: JSON, 7, 8, 9, 13]. This approach leverages existing imaging data to proactively detect cardiovascular disease without additional patient burden or cost, representing a significant innovation in preventive medicine and population health screening.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific details regarding customer support channels, service level agreements, or comprehensive documentation for either Tool A or Tool B. As both are enterprise-level healthcare AI solutions, professional support and documentation are implied, but no distinguishing information is available to declare a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | iCAC Device |
|---|---|---|
| Tool Name | RhythmAnalytics | iCAC Device |
| Company | Biofourmis Singapore Pte. | Bunkerhill Health |
| Primary Clinical Focus | Automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. | Detects and quantifies coronary artery calcium from routine chest CT scans, aiding in early cardiovascular disease detection. |
| Input Data Type | Single-lead ECG data (from FDA-cleared ECG devices like Holter, event recorders, wearable sensors) | Routine, non-contrast, non-gated chest CT scans |
| Key Output/Detection | Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats), beat-by-beat morphology computation, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis. | Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units. |
| Specialties Supported | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and iCAC Device.